Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series C | Alive

Total Raised


Last Raised

$57M | 2 yrs ago

About Novellus

Novellus is a precision oncology company that has developed a live-cell based assay to monitor the activity of signaling pathways. Using this platform, Novellus' solution helps biopharma companies identify new target mutations and expanded subgroups of cancer patients who are likely to respond to existing therapies.

Novellus Headquarters Location

Hadassah Medical Center Campus Jerusalem Bio-Park, 5th Floor

Jerusalem, 91120,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Novellus

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Novellus in 1 CB Insights research brief, most recently on Dec 14, 2020.

Expert Collections containing Novellus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novellus is included in 3 Expert Collections, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health Monitoring & Diagnostics

2,406 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

Novellus Patents

Novellus has filed 6 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Clusters of differentiation
  • Molecular biology
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Transcription factors, Genetics, Biotechnology, Clusters of differentiation


Application Date


Grant Date



Related Topics

Molecular biology, Transcription factors, Genetics, Biotechnology, Clusters of differentiation



Latest Novellus News

Novellus Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Novellus Rank

  • When was Novellus founded?

    Novellus was founded in 2012.

  • Where is Novellus's headquarters?

    Novellus's headquarters is located at Hadassah Medical Center Campus, Jerusalem.

  • What is Novellus's latest funding round?

    Novellus's latest funding round is Series C.

  • How much did Novellus raise?

    Novellus raised a total of $75.5M.

  • Who are the investors of Novellus?

    Investors of Novellus include Pontifax, OrbiMed Advisors, HBM Healthcare Investments, SR One, Wellington Management and 8 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.